NICE recommends implantable monitor to identify atrial fibrillation after stroke

BMJ ◽  
2020 ◽  
pp. m133
Author(s):  
Elisabeth Mahase
Keyword(s):  
Atrial Fibrillation ◽  
Implantable Monitor

scholarly journals Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: the atrial fibrillation detect study

EP Europace ◽  
2016 ◽  
Vol 19 (7) ◽  
pp. 1101-1108 ◽  
Author(s):  
Giuseppe Ciconte ◽  
Massimo Saviano ◽  
Luigi Giannelli ◽  
Zarko Calovic ◽  
Mario Baldi ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Implantable Monitor ◽  
Atrial Fibrillation Detection

Abstract 4307: New Insights into Surgical Atrial Fibrillation Ablation Therapy: Initial Experience with a Novel Permanently Implantable Heart Rhythm Monitor Device

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Thorsten Hanke ◽  
Antje Karlub ◽  
Efstratios Charitos ◽  
Axel Hagemann ◽  
Bernhard Graf ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Heart Rhythm ◽  
Holter Monitoring ◽  
Ecg Monitoring ◽  
Time Intervals ◽  
Ablation Therapy ◽  
Implantable Monitor ◽  
Monitor Device ◽  
Rhythm Monitoring ◽  
Af Recurrence

Introduction: Surgical atrial fibrillation (AF) therapy is gaining widespread acceptance among cardiothoracic surgeons. However, assessment of therapy success is until now solely based on short time -“snapshot”-rhythm surveillance often at irregular time intervals. In order to evaluate the ablation’s success we intraindividually compared two different types of follow-up strategies: conventional 24h-Holter monitoring and direct long time rhythm surveillance achieved by a new implantable monitor device (IRMD). Methods: 20 cardiac surgical patients (male 16, mean age 69±9y) with a mean AF of 30±48m (paroxysmal n=7, persistent n=9, long standing persistent n=4) were treated intraoperatively with epicardial high intensity focus ultrasound (HIFU) ablation (+CABG n=10, +AVR n=5, +AVR/CABG n=2, +valve preserving ascending aorta replacement n=2, +endoaneurymoraphy n=1, lone atrial fibrillation n=1). Postoperative heart rhythm monitoring was accomplished in all patients with a 24h-Holter-monitor at prescheduled time intervals and additionally with a new implantable monitor device (Reveal XT, Medtronic®, MN, USA). A more than 0.5% of “time in AF” as reported by the IRMD was considered as recurrence of AF. Telemetry of the IRMD was performed simultaneously after completion of 24h-Holter monitoring. Results: During a mean FU of 8.7±1.4m a total of 29 24 h-Holter-monitors were obtained. Sinus rhythm was documented in 21, the IMRD however revealed AF recurrence in 11 of these cases. Thus, conventional 24 h ECG monitoring failed to identify AF recurrence in 59% of cases (p<0.027). Success rate after surgical ablation therapy (defined as freedom from AF recurrence of more than 0.5% of observational period) was 72% with 24h Holter monitoring, but only 35% using continuous ECG monitoring with IRMD. Conclusion: In order to evaluate better “real life” outcomes after atrial fibrillation ablation therapy, long term continuous heart rhythm surveillance instead of -“snapshot” - heart rhythm monitoring is mandatory. This is particularly important for the decision to alter medical therapies, e.g. oral anticoagulation or antiarrhythmic treatment.

scholarly journals Use of an Implantable Monitor to Detect Arrhythmia Recurrences and Select Patients for Early Repeat Catheter Ablation for Atrial Fibrillation

2011 ◽  
Vol 4 (6) ◽  
pp. 823-831 ◽  
Author(s):  
Evgeny Pokushalov ◽  
Alexander Romanov ◽  
Giorgio Corbucci ◽  
Sergey Artyomenko ◽  
Alex Turov ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Catheter Ablation ◽  
Implantable Monitor
Sign in / Sign up

Export Citation Format

Share Document